<DOC>
	<DOCNO>NCT00825565</DOCNO>
	<brief_summary>The purpose study determine safe effective allantoin 3 % cream ( Alwextin ) improve heal recurrent skin lesion reduce overall blistering people epidermolysis bullosa ( EB ) . Allantoin 3 % cream apply topically entire body daily .</brief_summary>
	<brief_title>Study AlwextinÂ® Cream Treating Epidermolysis Bullosa</brief_title>
	<detailed_description>Potential subject come screen visit . Eligible subject baseline assessment perform provide study medication , allantoin 3 % cream . Subjects instruct apply study medication entire body daily keep daily record study medication use . Subjects return every 4 week total 12 week repeat assessment .</detailed_description>
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<mesh_term>Allantoin</mesh_term>
	<criteria>history epidermolysis bullosa use skin product contain allantoin 30 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Epidermolysis bullosa</keyword>
</DOC>